By Dr. Ray Butts, Chief Research Officer / Co-Founder of Torrentia™ Medical Education— April 2026

Most clinicians were taught to think about dry needling in one lane:

Find the trigger point → needle it → get a twitch → pain decreases.

That’s not wrong. It’s just incomplete.

When dry needling is used with intentional mechanical input (winding, pistoning as appropriate) and—when clinically indicated—electrical stimulation, we’re no longer talking about a simple “local release” narrative. We’re talking about a treatment that can influence pain through multiple biological layers:

• Peripheral chemistry (e.g., adenosine signaling)

• Spinal segment modulation (e.g., gating + inhibitory interneurons)

• Descending inhibition (DNIC / conditioned pain modulation)

• Neuroimmune and connective-tissue mechanobiology (mechanotransduction)

• Neuromuscular junction behavior (motor output + re-education potential)

This article is built from a Torrentia conversation I had with Dr. Brus Layson, but it’s not “just a transcript recap.” It’s a framework: a way to think, dose, explain, and integrate dry needling like a serious clinical tool.

What the current evidence is actually starting to support

In 2025, a systematic review and meta-analysis specifically evaluated neurophysiological effects of dry needling, including outcomes like conditioned pain modulation (CPM) and temporal summation—not just symptom scales. That matters, because it pulls dry needling out of the “placebo vs. magic” debate and back into measurable neurophysiology.

📊 Source: Neurophysiological Effects of Dry Needling: A Systematic Review and Meta-analysis
📅 Data Period: literature searched through October 2024 (published 2025)
⭐ Confidence: High (systematic review/meta-analysis in a major rehab journal family)

That doesn’t mean dry needling is a cure-all. It means the question is no longer “does anything happen?” The question is: what’s happening, and how do we dose it deliberately?

Mechanism #1: Peripheral analgesia — adenosine is the cleanest story we have

If you want one peripheral mechanism that is coherent, testable, and experimentally supported, it’s this:

Mechanical stimulation can elevate extracellular ATP metabolites locally, increasing adenosine; adenosine can reduce nociception via A1 receptors.

The Goldman et al. Nature Neuroscience paper is the classic anchor here: local adenosine elevation during acupuncture in a mouse model and dependence on A1 receptor expression for the antinociceptive effect.

📊 Source: Goldman et al., Nature Neuroscience (2010)
📅 Data Period: experimental (preclinical)
⭐ Confidence: High for mechanism; Medium for direct clinical translation (species + protocol differences)

Here’s the practical clinical bridge:

• You and I are not measuring adenosine in the clinic.

• But we can dose mechanical stimulation and monitor the patient’s physiologic response.

That’s where the traditional “de qi” discussion becomes useful when we demystify it..

“De qi” is not mysticism. It’s dosing feedback.

In the interview, I said something that tends to make people uncomfortable:

If you’re not getting an adequate mechanical signal, you’re not getting the downstream biology you think you’re getting.

Clinically, the best proxy we have is the patient’s report of a sensation consistent with adequate stimulation: deep ache, pressure, spreading warmth, reproduction of symptoms—tolerable, not traumatic.

Is that sensation a perfect biomarker? No.

Is it useful feedback for dosing mechanotransduction? Yes—when used responsibly.

A key point: the dose is patient-dependent. Hypersensitive patients may need very little. Less sensitive patients may need more. The target is not “make them suffer.” The target is: enough mechanical input to engage the physiology, without generating threat and guarding.

Mechanism #2: Spinal modulation — gating is an inhibition problem

Gate control is often taught like a trivia fact. Clinically, it’s more useful when you treat it as an inhibitory capacity problem at the dorsal horn.

• The substantia gelatinosa region contains inhibitory interneurons.

• When inhibitory interneuron activity is up, nociceptive transmission is down.

• Electrical stimulation (including e-stim via needles, when appropriate) can bias afferent input in a way that favors inhibition.

If you want a broader modern framing, this overlaps with how we think about segmental inhibition and the balance of facilitatory vs inhibitory processes at the spinal level.

This is also why “dry needling with electricity” is not simply a comfort add-on. It changes the neurophysiologic input.

Mechanism #3: DNIC / conditioned pain modulation — “pain inhibits pain” done on purpose

DNIC (called conditioned pain modulation in human literature) describes a reproducible phenomenon: a noxious input in one area can reduce pain processing in another.

A 2025 review summarizes the neurochemical systems involved and emphasizes monoaminergic (noradrenergic + serotonergic) and opioidergic contributions.

📊 Source: Diffuse Noxious Inhibitory Controls in Chronic Pain States (International Journal of Molecular Sciences)
📅 Data Period: review with emphasis on preclinical models through 2024 (published Jan 2025)
⭐ Confidence: High for DNIC/CPM concept and systems involved; Medium for mapping any single clinical technique to a specific neurotransmitter pathway

This matters clinically because it explains why a well-dosed needling input—especially when paired with meaningful manual/e-stim stimulation—can reduce pain beyond the immediate tissue neighborhood.

Why distal needling can work (and why acupuncturists needle the hand for neck pain)

The “distal points” question is where clinicians either roll their eyes or over-romanticize acupuncture. I prefer a third option: explain it in neuroimmune terms.

Needling can influence mast cells and mediator release in mechanistic models; histamine is strongly tied to itch signaling.

So here’s the relevant logic:

• Pain and itch interact.

• If itch and pain are processed in different segments and reach higher centers, itch can alter pain experience centrally (and pain can inhibit itch at spinal levels depending on how signals converge).

That’s a plausible justification for why some distal strategies may influence pain experience—without pretending every point selection is magic.

Neuromuscular junctions: why “trigger point dry needling” can be reframed as neuromuscular re-education

Trigger point models are messy, but clinicians recognize the pattern:

• local hypertonicity

• irritability

• reduced tolerance to load

• altered motor control

My argument is that needling is not just chasing a knot. It’s influencing motor behavior by changing input-output dynamics.

In the transcript, we discussed:

• an “energy crisis” environment

• chemical mediators that shift tissue sensitivity

• excessive acetylcholine persistence at the NMJ as a conceptual model for sustained activity

Then the clinical logic:

• needle stimulation drives afferent input

• that input can influence motor pools

• twitch response + perfusion change the environment

• electrical stimulation can be used (in appropriate contexts) to drive motor-unit effects

If you’re documenting or communicating with stakeholders, this is where you can responsibly say:

“This intervention is being used as neuromuscular re-education by influencing motor output and local tissue environment.”

You must still pair it with movement retraining, because needling doesn’t teach the CNS a better option by itself. It reduces constraints so the system can accept a better program.

Tissue remodeling: dry needling and shockwave share a language

This is the piece most people miss.

If dry needling can influence tissue structure over time, TRPV1 cannot be the only relevant receptor story. We have to talk about connective tissue mechanotransduction.

Helene Langevin’s work has been foundational in shifting the acupuncture conversation toward connective tissue responses and mechanotransduction. A 2025 paper reviewing acupuncture mechanics and connective tissue mechanobiology summarizes how mechanical stimulation can drive cytoskeletal remodeling and fibroblast responses.

📊 Source: Integrative research on the mechanisms of acupuncture mechanics and … (2025 review)
📅 Data Period: synthesis of prior mechanobiology literature (published 2025)
⭐ Confidence: Medium–High for mechanotransduction plausibility; Medium for direct “needle technique → specific enzyme” claims in humans

Here’s the key clinical connection:

• Shockwave is a mechanotransduction intervention (commonly discussed via integrin-related signaling).

• Dry needling with meaningful mechanical input can plausibly intersect with similar mechanobiology pathways in connective tissue, even if the exact receptors differ by tissue and technique.

That’s why, clinically, I often view them as additive tools—not competing tools—when used within a coherent plan.

Angiogenesis: don’t ignore perfusion

Even clinicians who disagree about everything else tend to agree on one observation:

Needling can increase local perfusion.

Perfusion changes matter for:

• metabolite clearance

• tissue oxygenation

• sensitivity modulation

• loading tolerance

And when the mechanotransduction conversation includes vascular signaling (e.g., VEGF pathways), we’re back to the same lesson:

If you don’t dose the mechanical stimulus, you don’t earn the downstream response.

The clinical method: how I think about dosing dry needling

I want you to stop asking, “Where do I stick the needle?”

Start asking:

1) What is the target mechanism today?

• Peripheral analgesia?

• Spinal inhibition / gating?

• Descending inhibition (DNIC/CPM)?

• NMJ reset / motor-unit behavior?

• Tissue mechanotransduction/remodeling?

2) What is the appropriate intensity for this patient’s threat system?

• hypersensitive: smaller dose, more safety cues, less stimulation

• hyposensitive: higher mechanical dose, still within tolerable bounds

3) What is the integration plan immediately after?

This is where most care fails.

Dry needling can reduce constraints. Your next job is to teach the system what to do with that window:

• breathing and downregulation (when appropriate)

• graded exposure to tolerated motion

• specific loading

• motor-control tasks tied to the patient’s goal

The “recipe” principle: dry needling should rarely be a standalone intervention

In the interview, I said something I’ll repeat here:

Dry needling is powerful. But it’s most powerful when it improves the recipe—not when it becomes the recipe.

Use it additively with:

• exercise programming

• manual therapy (when appropriate)

• emerging mechanotransduction tools (e.g., shockwave) when clinically justified

The goal is not a flashy modality stack.

The goal is higher specificity and better outcomes.

Guardrails: professional credibility requires discipline

A few boundaries matter—especially in public-facing education:

• Don’t promise outcomes.

• Don’t claim disease remission without strong human evidence.

• Don’t confuse mechanistic plausibility with clinical certainty.

If you can’t explain what you’re doing and why, in plain clinical language, you shouldn’t be doing it.

Where this is going (Torrentia’s position)

Torrentia’s stance is not “dry needling is everything.”

It’s this:

Dry needling is one of the most misunderstood tools in rehab.
When used with precision, it can influence pain and function through multiple physiologic layers.
When used casually, it becomes a superstition with needles.

Our mission is to move clinicians toward evidence-informed clinical leadership—where tools are selected for mechanisms, dosed for the individual, and integrated into systems that produce outcomes.

If you want the next step

If you’re reading this as a clinician and thinking, “I need a tighter framework than the weekend course approach,” here’s what I recommend:

1. Learn to identify the dominant mechanism per visit

2. Learn dosing logic that respects sensitivity and threat

3. Build integration sequences (movement + loading) that capitalize on the post-needling window

4. Understand how dry needling fits alongside mechanotransduction tools like shockwave—without random stacking

That’s the difference between “I needle trigger points” and I run a system that changes outcomes.

Research citations recap

• Neurophysiological effects of dry needling: systematic review/meta-analysis (search through Oct 2024).

• DNIC/CPM review (published Jan 2025) highlighting noradrenergic/serotonergic/opioidergic contributions.

• Adenosine A1 receptor mechanism for acupuncture analgesia (Goldman et al., 2010) and related commentary.

• Langevin background (connective tissue + mechanotransduction focus) and 2025 connective tissue mechanobiology synthesis.

Watch the Full Conversation

Read about Tendon Repair Is Not a “Protocol.” It’s a Sequence.